| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.08 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |